These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018. Mbaeyi C; Alleman MM; Ehrhardt D; Wiesen E; Burns CC; Liu H; Ewetola R; Seakamela L; Mdodo R; Ndoutabe M; Wenye PK; Riziki Y; Borus P; Kamugisha C; Wassilak SGF MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):225-230. PubMed ID: 30845121 [TBL] [Abstract][Full Text] [Related]
27. Polio outbreak response in Ethiopia. Mesfin G; Schluter W; Gebremariam A; Benti D; Bedada T; Beyene B; Yigzaw A; Taddess Z; Mbakuliyemo N; Babaniyi O East Afr Med J; 2008 May; 85(5):222-31. PubMed ID: 18814532 [TBL] [Abstract][Full Text] [Related]
28. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic. Molodecky NA; Jafari H; Safdar RM; Ahmed JA; Mahamud A; Bandyopadhyay AS; Shukla H; Quddus A; Zaffran M; Sutter RW; Grassly NC; Blake IM Vaccine; 2023 Apr; 41 Suppl 1():A93-A104. PubMed ID: 34629206 [TBL] [Abstract][Full Text] [Related]
29. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
30. Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal. Harutyunyan V; Quddus A; Pallansch M; Zipursky S; Woods D; Ottosen A; Vertefeuille J; Lewis I Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A70-A78. PubMed ID: 35282924 [TBL] [Abstract][Full Text] [Related]
31. Field investigation and response to a vaccine-derived poliovirus pre-tOPV switch in Southwest Nigeria, October 2015. Fatiregun A; Famiyesin E; Bawa S; Ogunbodede N Pan Afr Med J; 2020; 37():6. PubMed ID: 32983324 [TBL] [Abstract][Full Text] [Related]
32. Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies. Voorman A; O'Reilly K; Lyons H; Goel AK; Touray K; Okiror S Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A105-A112. PubMed ID: 34483024 [TBL] [Abstract][Full Text] [Related]
33. Polio: The Disease that Reemerged after Six Years in Ethiopia. Tseha ST Ethiop J Health Sci; 2021 Jul; 31(4):897-902. PubMed ID: 34703190 [TBL] [Abstract][Full Text] [Related]
36. Strengthening acute flaccid paralysis surveillance post Ebola virus disease outbreak 2015 - 2017: the Liberia experience. Clarke A; Blidi N; Dahn B; Agbo C; Tuopileyi R; Rude MJ; Williams GS; Seid M; Gasasira A; Wambai Z; Skrip L; Nagbe T; Nyenswah T; Chukwudi JO; Johnson T; Talisuna A; Yahaya AA; Rajatonirina S; Fall IS Pan Afr Med J; 2019; 33(Suppl 2):2. PubMed ID: 31402963 [TBL] [Abstract][Full Text] [Related]
37. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status. Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328 [TBL] [Abstract][Full Text] [Related]